-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Acurx Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
- Acurx Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$4.12M, a 19.6% decline year-over-year.
- Acurx Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$16.7M, a 27.2% decline year-over-year.
- Acurx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$14.6M, a 20.5% decline from 2022.
- Acurx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$12.1M, a 5.14% increase from 2021.
- Acurx Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12.7M, a 177% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)